These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


447 related items for PubMed ID: 18277597

  • 1. [Discrepant results of ABO type of red cells and serum in a patient with acute myelogenous leukemia].
    Fujita A, Fujisawa S, Hyo R, Kuwabara H, Yamazaki E, Tomita N, Ishigatsubo Y.
    Rinsho Ketsueki; 2008 Jan; 49(1):51-4. PubMed ID: 18277597
    [Abstract] [Full Text] [Related]

  • 2. [Acute myelogenous leukemia associated with severe esophageal stricture after chemotherapy].
    Yata K, Yamada O, Iwato K, Kyo T, Otsuki T, Nakanishi H, Suetsugu Y, Mikami M, Wada H, Yawata Y, Sugihara T.
    Rinsho Ketsueki; 2002 Jan; 43(1):41-3. PubMed ID: 11868364
    [Abstract] [Full Text] [Related]

  • 3. [Acute myelogenous leukemia complicated with severe tumor lysis syndrome after a single day of idarubicin/cytarabine chemotherapy].
    Kikuchi T, Miyata A, Fujii S, Kikuchi T.
    Rinsho Ketsueki; 2003 Nov; 44(11):1113-6. PubMed ID: 14689878
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Acute monoblastic leukemia with tetrasomy 8].
    Kameoka J, Horiuchi T, Miyamura K, Miura I, Okuda M, Nomura J, Hirokawa M, Sawada K, Sasaki T.
    Rinsho Ketsueki; 2006 Aug; 47(8):770-6. PubMed ID: 16986717
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Acyclovir bioavailability in patients with acute myelogenous leukemia treated with daunorubicin and cytarabine.
    Sitar DS, Aoki FY, Bow EJ.
    J Clin Pharmacol; 2008 Aug; 48(8):995-8. PubMed ID: 18495946
    [No Abstract] [Full Text] [Related]

  • 9. [Severe aplastic anemia accompanied with abnormality of T cell subset and appearance of anti-BI antibody].
    Inada T, Abe K, Imamura N, Okada K, Kuramoto A.
    Rinsho Ketsueki; 1989 Aug; 30(8):1314-8. PubMed ID: 2601051
    [Abstract] [Full Text] [Related]

  • 10. [Therapeutic effect of priming induction regimen of CAG for newly diagnosed acute myeloid leukemia in elderly patients].
    Chen YJ, Zhang LQ, Li XL, Zhao XL, Wu DS, Shu YG, Chen FP.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 33(3):245-51. PubMed ID: 18382060
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Reappearance of acute myeloid leukemia after almost 23 years of continuous complete remission.
    Lee SH, Abebe L, Paietta E, Einzig A, Wiernik PH.
    Am J Hematol; 2009 Jul; 84(7):455-7. PubMed ID: 19507211
    [No Abstract] [Full Text] [Related]

  • 14. Low dose interleukin-2 following intensification therapy with high dose cytarabine for acute myelogenous leukemia in first complete remission.
    Stone RM, DeAngelo DJ, Janosova A, Galinsky I, Canning C, Ritz J, Soiffer RJ.
    Am J Hematol; 2008 Oct; 83(10):771-7. PubMed ID: 18756547
    [Abstract] [Full Text] [Related]

  • 15. Clinically significant autoantibodies--a case report.
    Sulochana PV, Sathyabhama S, Mathai J, Devi KS.
    Indian J Pathol Microbiol; 2003 Apr; 46(2):246-7. PubMed ID: 15022929
    [Abstract] [Full Text] [Related]

  • 16. Consolidation therapy: what should be the standard of care?
    Rowe JM.
    Best Pract Res Clin Haematol; 2008 Mar; 21(1):53-60. PubMed ID: 18342812
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Acute myelogenous leukemia developing in pregnancy with complete remission--a case report].
    Fukuoka K, Nishikawa K, Mizumoto Y, Shimoyama T, Mikasa K, Sawaki M, Narita N, Kato Y, Tsuzi Y, Moriyama I.
    Rinsho Ketsueki; 1989 Oct; 30(10):1859-64. PubMed ID: 2593254
    [Abstract] [Full Text] [Related]

  • 20. Effect of L-asparaginase combined with vincristine and prednisolone on acute myeloblastic leukemia (M0) associated with non-Hodgkin lymphoma.
    Horikoshi A, Takei K, Iriyama N, Uenogawa K, Ishizuka H, Shiraiwa H, Hosokawa Y, Sawada S, Kitoh T.
    Acta Haematol; 2009 Oct; 122(1):54-7. PubMed ID: 19816010
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.